Intercell AG is investing €15 million to acquire antibody technology directed at discovering new therapies for infectious disease including hospital-acquired infections. It is buying the technology from Cytos Biotechnology Ltd. ---Subscribe to MedNous to access this article--- Finance, Grants, Deals Company News
